Literature DB >> 21145411

Multiple antibacterial histone H2B proteins are expressed in tissues of American oyster.

Jung-Kil Seo1, Jeana Stephenson, Edward J Noga.   

Abstract

We have previously identified a histone H2B isomer (cvH2B-1) from tissue extracts of the bivalve mollusk, the American oyster (Crassostrea virginica). In this paper, we isolate an additional three antibacterial proteins from acidified gill extract by preparative acid-urea-polyacrylamide gel electrophoresis and reversed-phase high performance liquid chromatography. Extraction of these proteins from tissue was best accomplished by briefly boiling the tissues in a weak acetic acid solution. Addition of protease inhibitors while boiling resulted in somewhat lower yields, with one protein being totally absent with this method. Via mass spectrometry, the masses of one of these purified proteins was 13607.0Da (peak 2), which is consistent with the molecular weight of histone H2B. In addition, via western-blotting using anti-calf histone H2B antibody, all three proteins were positive and were thus named cvH2B-2, cvH2B-3 and cvH2B-4. The antibacterial activity of cvH2B-2 was similar to that of cvH2B-1, with activity against a Gram-positive bacterium (Lactococcus lactis subsp. lactis; minimum effective concentration [MEC] 52-57μg/mL) but inactive against Staphylococcus aureus (MEC>250μg/mL). However, both proteins had relatively potent activity against the Gram-negative oyster pathogen Vibrio parahemolyticus (MEC 11.5-14μg/mL) as well as the human pathogen Vibrio vulnificus (MEC 21.3-25.3μg/mL). cvH2B-3 and cvH2B-4 also had similarly strong activity against Vibrio vulnificus. These data provide further evidence for the antimicrobial function of histone H2B isomers in modulating bacterial populations in oyster tissues. The combined estimated concentrations of these histone H2B isomers were far above the inhibitory concentrations for the tested vibrios, including human pathogens. Our results indicate that the highly conserved histone proteins might be important components not only of immune defenses in oysters but have the potential to influence the abundance of a ubiquitous microbial resident of oyster tissues that is the major source of seafood-borne illness in humans. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145411     DOI: 10.1016/j.cbpb.2010.11.011

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  6 in total

1.  Antimicrobial histones and DNA traps in invertebrate immunity: evidences in Crassostrea gigas.

Authors:  Aurore C Poirier; Paulina Schmitt; Rafael D Rosa; Audrey S Vanhove; Sylvie Kieffer-Jaquinod; Tristan P Rubio; Guillaume M Charrière; Delphine Destoumieux-Garzón
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

2.  Novel histone-derived antimicrobial peptides use different antimicrobial mechanisms.

Authors:  Kathryn E Pavia; Sara A Spinella; Donald E Elmore
Journal:  Biochim Biophys Acta       Date:  2011-12-31

Review 3.  The interactions of Vibrio vulnificus and the oyster Crassostrea virginica.

Authors:  Brett Froelich; James D Oliver
Journal:  Microb Ecol       Date:  2013-01-03       Impact factor: 4.552

4.  Proteomic study of the brackish water mussel Mytilopsis leucophaeata.

Authors:  Feico Mah Schuurmans Stekhoven; Gerard van der Velde; Tsung-Han Lee; Andrew R Bottrill
Journal:  Zool Stud       Date:  2015-01-23       Impact factor: 2.058

5.  Extracellular Vesicles and Post-Translational Protein Deimination Signatures in Mollusca-The Blue Mussel (Mytilus edulis), Soft Shell Clam (Mya arenaria), Eastern Oyster (Crassostrea virginica) and Atlantic Jacknife Clam (Ensis leei).

Authors:  Timothy J Bowden; Igor Kraev; Sigrun Lange
Journal:  Biology (Basel)       Date:  2020-11-25

Review 6.  Resistance to Antimicrobial Peptides in Vibrios.

Authors:  Delphine Destoumieux-Garzón; Marylise Duperthuy; Audrey Sophie Vanhove; Paulina Schmitt; Sun Nyunt Wai
Journal:  Antibiotics (Basel)       Date:  2014-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.